TRIXIE NEWKIRK: Open Payments
NPI 1538144886 · KAUFMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 34 payments from 14 companies in 2025. Trend: 2023 $494 · 2024 $670 · 2025 $747
Food & beverage: $747
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $151 |
| PFIZER INC. | 8 | $137 |
| Lilly USA, LLC | 5 | $83 |
| SANOFI-AVENTIS U.S. LLC | 2 | $74 |
| Phathom Pharmaceuticals, Inc. | 3 | $51 |
| Abbott Laboratories | 2 | $47 |
| Corcept Therapeutics | 1 | $43 |
| Renalytix AI, Inc. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $25 |
Products named: AIRSUPRA, ELIQUIS, TZIELD, MOUNJARO, VOQUEZNA, FREESTYLE LIBRE 3, Korlym, FARXIGA.
Industry payments across TX — which companies pay providers there.
